Consumers should immediately stop using LIANTRAL heavy duty storage rack wall mounts due to collapse risk

• Sold on Amazon.com November 2023 to July 2025

• CPSC urges consumers to stop use and dispose of the product

The Consumer Product Safety Commission is warning consumers to immediately stop using LIANTRAL Heavy Duty Storage Rack Wall Mounts sold on Amazon.com. The racks have been reported to collapse, buckle or fail, creating a risk of serious injury.

CPSC has received 13 reports of these storage racks failing. The products were available online from November 2023 to July 2025.

The hazard

The LIANTRAL storage racks may collapse or experience weld failure, posing a significant impact hazard to users.

What to do

Consumers should stop using these storage racks immediately and dispose of them as advised by CPSC.

Company contact

Report incidents involving these storage racks, or any product-related injury, on www.SaferProducts.gov. Call CPSCs Hotline at 800-638-2772 (TTY 800-638-8270).

Source

Read the official warning

Major safety proposals get the ax from the new Trump-appointed safety regulators

How a standard vaccine sparked impressive immune defenses in pancreatic and colorectal cancer patients

• Ready-made, not custom: The ELI-002 2P vaccine is an "off-the-shelf" therapy targeting KRAS mutations common in pancreatic and colorectal cancers.

• Strong immune reactions linked to better outcomes: Patients who mounted robust T-cell responses saw significantly longer relapse-free and overall survival than those with weaker responses.

• Promising but early findings: Though the results are encouraging, this was a small Phase 1 trial without controls; larger studies are needed to confirm its benefits.

Imagine a cancer vaccine you dont have to personalize one thats made in advance and can be given to anyone whose cancer shares a specific mutation.

Thats precisely what researchers at UCLA and their collaborators are exploring with ELI-002 2P. Its a peptide-based vaccine designed to train your immune system to recognize and attack KRAS-mutated cancer cells mutations found in about 90% of pancreatic cancers and half of colorectal cancers.

This new approach could offer a more accessible, cost-effective alternative to highly tailored immunotherapies.

This is an exciting advance for patients with KRAS-driven cancers, particularly pancreatic cancer, where recurrence after standard treatment is almost a given and effective therapies are limited, first author of the study Zev Wainberg, MD, said in a news release.

We observed that patients who developed strong immune responses to the vaccine remained disease-free and survived for much longer than expected.

A look at the study

This was a Phase 1 clinical trial called AMPLIFY-201, involving 25 patients 20 with pancreatic cancer and five with colorectal cancer who had already undergone surgery and showed signs of minimal residual disease.

The vaccine was composed of peptides representing common KRAS mutations (like G12D and G12R), combined with an adjuvant known as CpG-7909 to stimulate the immune system, and administered in a way that targets the lymph nodes.

Over a median follow-up of almost 20 months, researchers monitored patients immune responses, tracked how long they remained disease-free, and measured overall survival.

Results & what they mean

Among the 25 participants, a majority 17 showed strong immune responses, meaning their T cells specifically targeted the KRAS mutant proteins.

Those patients had notably better outcomes: for example, their median relapse-free survival wasnt reached yet, compared to just about three months in those with weaker immune responses.

Similarly, their median overall survival also wasnt reached, versus around 16 months for the less responsive group.

In terms of raw numbers, only four of the strong-responders died during follow-up, versus seven of the eight weak-responders. In other words, the vaccine appeared to boost the immune systems ability to keep cancer at bay at least for those who responded well.

That said, experts and the researchers are clear: these are early, promising signals, but further testing in larger, controlled trials is essential.

Targeting KRAS has long been considered one of the difficult challenges in cancer therapy, Dr. Wainberg said. This study shows that the ELI-002 2P vaccine can safely and effectively train the immune system to recognize and fight cancer-driving mutations. It offers a promising approach to generating precise and durable immune responses without the complexity or cost of fully personalized vaccines.

How everyday worries are hijacking our rest and what to do about it

• Money troubles top the list 78% of Americans report losing sleep over financial concerns.

• Work, safety, and politics also weigh heavily with concerns about job security (56%), crime (61%), and politics (56%) disrupting sleep.

• Small changes matter strategies like unplugging before bed, journaling, and gentle self-talk can help tame racing thoughts.

Sleep should be a time to recharge, but for many Americans, bedtime has become the hour when worries get louder.

According to a new survey by the American Academy of Sleep Medicine (AASM), stressors like money, work, crime, and politics are among the top reasons people are struggling to rest. Experts warn that these racing thoughts dont just steal sleep they also chip away at health and resilience during the day.

In todays high-stress world, its easy to become overwhelmed and many people carry their worries to bed with them, Dr. Andrew Spector, sleep medicine physician and AASM spokesperson, said in a news release.

This is magnified by a lifestyle where even a quick walk to the bathroom might include a check of the latest headlines or social media posts, leaving little time in the day other than bedtime for the mind to process all of these fears. When your stress level is too high when you go to bed, your sleep suffers, and that affects your physical and mental health.

The survey

The AASM survey, conducted in June 2025, polled 2,005 U.S. adults to understand what keeps them awake at night.

Participants were asked about a range of stressors, including finances, job stability, crime, politics, and even new technologies such as artificial intelligence. The results highlight just how widespread the problem of worry-driven insomnia has become.

The results

The survey results show that financial concerns top the list of what keeps Americans awake at night: 78% of Americans report losing sleep over money. Work is another major culprit 65% struggle with work-related thoughts at night, and 56% worry about job security.

Safety is also on peoples minds, with 61% saying concerns about crime or violence have disrupted their rest. Politics has grown into a larger factor too: 56% cite it as a sleep disruptor, up from 46% just one year earlier. Even technology plays a role, with 39% losing sleep over AI and related developments.

Sleep is essential to overall well-being, so its important to learn how to compartmentalize your worries to avoid having them interfere with your sleep, Dr. Spector said. The good news is that even small, consistent changes to your bedtime routine can lead to meaningful, long-term improvements.

Tips: How to calm your mind for better rest

While the problems themselves may not vanish overnight, there are ways to quiet your thoughts at bedtime. The AASM suggests:

• Unplug an hour before bed by stepping away from news and social media.

• Schedule worry time during the day so concerns dont flood your mind at night.

• Jot worries down in a notebook to reassure yourself youll address them later.

• Exercise regularly to manage stress, but avoid intense workouts close to bedtime.

• Ease up on sleep pressuredont let worrying about sleep become another source of anxiety.

• Seek help from a therapist or counselor if worries consistently prevent rest.
  

When we sleep better, we feel better physically, mentally, and emotionally, Dr, Spector said. Getting quality sleep is one of the most powerful tools we have to build resilience and face lifes daily challenges.